Cargando…
Age related medication for addiction treatment (MAT) use for opioid use disorder among Medicaid-insured patients in New York
BACKGROUND: Medication for addiction treatment (MAT) has received much attention in recent years for treating individuals with opioid use disorders (OUD). However, these medications have been significantly underused among particular subgroups. In this paper, we describe the age distribution of treat...
Autores principales: | Neighbors, Charles J., Choi, Sugy, Healy, Shannon, Yerneni, Rajeev, Sun, Tong, Shapoval, Liudmila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593566/ https://www.ncbi.nlm.nih.gov/pubmed/31238952 http://dx.doi.org/10.1186/s13011-019-0215-4 |
Ejemplares similares
-
Effects of a New York Medicaid Care Management Program on Substance Use Disorder Treatment Services and Medicaid Spending: Implications for Defining the Target Population
por: Neighbors, Charles J, et al.
Publicado: (2022) -
Validation of an Optimized Algorithm for Identifying Persons Living With Diagnosed HIV From New York State Medicaid Data, 2006–2014
por: Macinski, Sarah E, et al.
Publicado: (2020) -
Mixed-methods study to examine the response of opioid addiction treatment programmes to COVID-19: a study protocol
por: Choi, Sugy, et al.
Publicado: (2022) -
Performance Metrics of Substance Use Disorder Care Among Medicaid Enrollees in New York, New York
por: Alegría, Margarita, et al.
Publicado: (2022) -
The Role of Marketplace Policy on Welcome Mat Effects for Children Eligible for Medicaid or the Children’s Health Insurance Program
por: Hudson, Julie L., et al.
Publicado: (2020)